Edison T. Liu, M.D.

President, CEO

Conducts research focused on the functional genomics of breast cancer through an exploration of the entire genomic space.

Dr. Liu is the president and CEO of The Jackson Laboratory. Previously, he was the founding executive director of the Genome Institute of Singapore (2001-2011), and was the president of the Human Genome Organization (HUGO) from 2007-2013. Between 1997 and 2001, he was the scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md., where he was in charge of the intramural clinical translational science programs.

From 1987 to 1996, Dr. Liu was a faculty member at the University of North Carolina at Chapel Hill, where he was the director of the UNC Lineberger Comprehensive Cancer Center's Specialized Program of Research Excellence in Breast Cancer; the director of the Laboratory of Molecular Epidemiology at UNC's School of Public Health; chief of Medical Genetics; and the chair of the Correlative Science Committee of the national cooperative clinical trials group, CALGB. Dr. Liu is an international expert in cancer biology, genomics, human genetics, molecular epidemiology and translational medicine.

Dr. Liu's own scientific research has focused on the functional genomics of human cancers, particularly breast cancer, uncovering new oncogenes, and deciphering on a genomic scale the dynamics of gene regulation that modulate cancer biology. He has authored over 300 scientific papers and reviews, and co-authored two books. He obtained his B.S. in chemistry and psychology, as well as his M.D., at Stanford University. He served his internship and residency at Washington University's Barnes Hospital in St. Louis, followed by an oncology fellowship at Stanford. From 1982 to 1987 he was at the University of California, San Francisco, at the G.W. Hooper Foundation.

Download CV

Grants, honors and accomplishments

2014 April - 2014 Chen Award for Distinguished Academic Achievement in Human Genetic and Genomic Research (from the Human Genome Organization)

2013 January - Elected, Fellow of the Connecticut Academy of Sciences and Engineering 

2010 October - Fellow of the Hastings Center (New York, Elected Membership) 

2010-2013 - Re-elected - President, Human Genome Organization (HUGO) 

2008 - Elected, Foreign Associate Member, European Molecular Biology Organization (EMBO) 

July 2007 - Awarded Doctor of Medical Sciences honoris causa, Queen’s University, Belfast September 

June 2007-2010 - Elected – President, Human Genome Organization (HUGO) 

September 2003 - Public Service Medal (National Day, 2003): for work in controlling SARS in Singapore (given by the Office of the President, Republic of Singapore) 

April 2000 - Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin. 

April 1999-2001 - Elected-Board of Directors, American Association for Cancer Research 

October 1996 - 1996 Brinker International Award for Breast Cancer Research - Basic Research Award 

July 1995 - American Society of Clinical Investigation (Elected Membership) 

December 1991-November1996 - Leukemia Society Scholar 

October 1990-1993 - Komen Foundation Award for Breast Cancer Research (funding fellow salary) 

July 1990-June 1994 - Jefferson Pilot Award: University of North Carolina at Chapel Hill, Junior Faculty Award for Research Excellence 

July 1985-1988 - Clinical Investigator Award, National Cancer Institute, K08- CA01036-02, Preceptor: Dr. J. Michael Bishop. 

September 1983-1985 - Damon Runyan Cancer Fund Fellowship Preceptor: Dr. J. Michael Bishop (UCSF) 

July-September 1974 - Ford Foundation Fellowship for Intensive Studies in Chinese, Stanford University 

June 1973 - Phi Beta Kappa, Stanford University 

June-September 1972 - National Science Foundation Fellowship in Chemistry 1972. To study the photoconversion of aziridines to ethylene for its agriculture applications. Preceptor: Dr. J. D. White